Cardiometabolic disease is a global health problem. A recent study found that only 12.2% of Americans are metabolically healthy, while CVD remains the leading cause of mortality among adults.
We generally think of cardiometabolic disease as a cluster of 4 pathophysiologies: dyslipidemia, insulin resistance and diabetes, fatty liver, and hypertension.
There are multiple dysfunctions that contribute to cardiometabolic disease progression but arguably the most prominent driver of disease progression and cardiovascular events is inflammation.
This is a prime opportunity for pharmacists, the most accessible healthcare professionals, to make a vast impact on an alarming public health issue by promoting healthy lifestyle interventions.
You’re invited to a FREE roundtable in which we’ll discuss inflammation as a central driver of cardiometabolic disease and the FxMed approach to addressing inflammation through lifestyle and nutrition.
Join Lara Zakaria, PharmD, IFMCP, Melody Hartzler, PharmD, BCACP and me (Lauren Castle, PharmD, MS, AFMC) for this pertinent and lively discussion!
Inflammation as a Driver of Cardiometabolic Diseases
Tuesday, April 19 at 8:30 pm ET
| Save your seat for the roundtable! |
We look forward to engaging with you next Tuesday!
Responses